Reuters -- Belgium’s radiotherapy implant maker International Brachytherapy has signed a deal to re-enter the lucrative U.S. market two years after closing its loss-making operations in the region.
Reuters -- Belgium’s radiotherapy implant maker International Brachytherapy has signed a deal to re-enter the lucrative U.S. market two years after closing its loss-making operations in the region.
